Alphabet drives cloud and AI momentum, Exxon Mobil boosts energy projects, and AbbVie rides strong drug launches despite ...

Stock selection in the information technology and financials sectors contributed to the relative performance of the fund.

Alphabet, Exxon Mobil, and AbbVie remain Zacks' top coverage picks as each navigates industry shifts while driving long-term ...

Daily stock price moves often dominate headlines, but shifts in fundamental ranking scores can reveal a deeper story. This ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Evolus Inc. lost a third of its value after lower-than-expected second quarter results, reflecting weakened demand within the ...

Glenmark Pharmaceuticals to close ISB 2001 transaction in September, focusing on high-margin branded products for growth.

Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in th ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

Interius is working on a more efficient way to deliver CAR-T therapy to patients. Unlock Digital Access for unlimited access to Inquirer.com and The Inquirer App, plus 5 articles per month to gift to ...

AbbVie Inc. has turned heads recently with a notable uptick in stock searches. Over the last month, its shares soared by +9.2 ...